Royce & Associates’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $39.7M | Buy |
759,712
+81,210
| +12% | +$4.87M | 0.39% | 59 |
|
|
2025
Q4 | $39.9M | Buy |
678,502
+18,468
| +3% | +$1.12M | 0.4% | 58 |
|
|
2025
Q3 | $36.7M | Sell |
660,034
-210,853
| -24% | -$11.3M | 0.37% | 70 |
|
|
2025
Q2 | $44.8M | Buy |
870,887
+702
| +0.1% | +$35.3K | 0.46% | 46 |
|
|
2025
Q1 | $51M | Buy |
870,185
+9,434
| +1% | +$639K | 0.55% | 27 |
|
|
2024
Q4 | $62M | Buy |
860,751
+15,353
| +2% | +$1.13M | 0.58% | 28 |
|
|
2024
Q3 | $67.6M | Buy |
845,398
+17,296
| +2% | +$1.3M | 0.61% | 22 |
|
|
2024
Q2 | $59.3M | Buy |
828,102
+31,538
| +4% | +$2.32M | 0.55% | 28 |
|
|
2024
Q1 | $56.1M | Buy |
796,564
+113,094
| +17% | +$8.09M | 0.5% | 34 |
|
|
2023
Q4 | $52.7M | Buy |
683,470
+9,185
| +1% | +$605K | 0.49% | 41 |
|
|
2023
Q3 | $45.9M | Buy |
674,285
+128,646
| +24% | +$10.2M | 0.47% | 47 |
|
|
2023
Q2 | $44.5M | Sell |
545,639
-149,564
| -22% | -$12M | 0.43% | 49 |
|
|
2023
Q1 | $51.6M | Buy |
695,203
+243,089
| +54% | +$18.7M | 0.52% | 36 |
|
|
2022
Q4 | $37.5M | Buy |
452,114
+46,122
| +11% | +$3.66M | 0.39% | 54 |
|
|
2022
Q3 | $28.8M | Buy |
405,992
+22,552
| +6% | +$1.95M | 0.33% | 70 |
|
|
2022
Q2 | $33.2M | Buy |
383,440
+65,956
| +21% | +$6.18M | 0.34% | 66 |
|
|
2022
Q1 | $34.4M | Buy |
317,484
+11,712
| +4% | +$1.21M | 0.29% | 74 |
|
|
2021
Q4 | $39.5M | Sell |
305,772
-9,864
| -3% | -$1.21M | 0.3% | 69 |
|
|
2021
Q3 | $38.2M | Sell |
315,636
-193,396
| -38% | -$23.5M | 0.29% | 74 |
|
|
2021
Q2 | $57.3M | Sell |
509,032
-211,796
| -29% | -$22.3M | 0.39% | 42 |
|
|
2021
Q1 | $68.8M | Sell |
720,828
-41,516
| -5% | -$3.79M | 0.46% | 30 |
|
|
2020
Q4 | $60.5M | Sell |
762,344
-83,524
| -10% | -$6.05M | 0.5% | 33 |
|
|
2020
Q3 | $52.4M | Buy |
845,868
+3,532
| +0.4% | +$230K | 0.57% | 25 |
|
|
2020
Q2 | $55.6M | Sell |
842,336
-49,600
| -6% | -$2.97M | 0.61% | 22 |
|
|
2020
Q1 | $42.3M | Sell |
891,936
-7,472
| -0.8% | -$374K | 0.58% | 34 |
|
|
2019
Q4 | $49.4M | Sell |
899,408
-141,572
| -14% | -$7.43M | 0.44% | 51 |
|
|
2019
Q3 | $50.9M | Buy |
1,040,980
+51,364
| +5% | +$2.58M | 0.47% | 48 |
|
|
2019
Q2 | $51.6M | Sell |
989,616
-72,140
| -7% | -$3.64M | 0.47% | 47 |
|
|
2019
Q1 | $52.7M | Sell |
1,061,756
-133,600
| -11% | -$6.01M | 0.45% | 51 |
|
|
2018
Q4 | $43.2M | Sell |
1,195,356
-158,052
| -12% | -$6.6M | 0.39% | 55 |
|
|
2018
Q3 | $69.1M | Sell |
1,353,408
-608,812
| -31% | -$27M | 0.48% | 37 |
|
|
2018
Q2 | $72.6M | Sell |
1,962,220
-319,200
| -14% | -$12.2M | 0.5% | 36 |
|
|
2018
Q1 | $86.1M | Sell |
2,281,420
-209,484
| -8% | -$7.4M | 0.6% | 24 |
|
|
2017
Q4 | $80.7M | Sell |
2,490,904
-145,132
| -6% | -$4.61M | 0.54% | 32 |
|
|
2017
Q3 | $79.7M | Sell |
2,636,036
-285,400
| -10% | -$8.47M | 0.53% | 33 |
|
|
2017
Q2 | $85.8M | Sell |
2,921,436
-298,000
| -9% | -$8.15M | 0.57% | 29 |
|
|
2017
Q1 | $81.8M | Buy |
3,219,436
+118,400
| +4% | +$3.06M | 0.54% | 29 |
|
|
2016
Q4 | $79.7M | Buy |
3,101,036
+135,600
| +5% | +$3.56M | 0.51% | 33 |
|
|
2016
Q3 | $81.2M | Sell |
2,965,436
-99,600
| -3% | -$2.74M | 0.53% | 29 |
|
|
2016
Q2 | $86.4M | Sell |
3,065,036
-274,000
| -8% | -$7.04M | 0.57% | 25 |
|
|
2016
Q1 | $78.9M | Sell |
3,339,036
-295,240
| -8% | -$6.5M | 0.5% | 31 |
|
|
2015
Q4 | $81.8M | Buy |
3,634,276
+367,160
| +11% | +$8.37M | 0.49% | 36 |
|
|
2015
Q3 | $75.5M | Buy |
3,267,116
+1,245,280
| +62% | +$31.2M | 0.4% | 53 |
|
|
2015
Q2 | $49.8M | Buy |
2,021,836
+416,296
| +26% | +$10.4M | 0.21% | 124 |
|
|
2015
Q1 | $40.3M | Sell |
1,605,540
-841,760
| -34% | -$20M | 0.15% | 174 |
|
|
2014
Q4 | $56.5M | Sell |
2,447,300
-33,520
| -1% | -$767K | 0.2% | 138 |
|
|
2014
Q3 | $58M | Sell |
2,480,820
-86,180
| -3% | -$2.02M | 0.2% | 131 |
|
|
2014
Q2 | $59.4M | Sell |
2,567,000
-41,000
| -2% | -$906K | 0.18% | 143 |
|
|
2014
Q1 | $55.7M | Sell |
2,608,000
-251,084
| -9% | -$5.65M | 0.16% | 156 |
|
|
2013
Q4 | $67.7M | Buy |
2,859,084
+751,600
| +36% | +$16.3M | 0.19% | 141 |
|
|
2013
Q3 | $42.2M | Buy |
2,107,484
+268,284
| +15% | +$5.09M | 0.13% | 210 |
|
|
2013
Q2 | $31.8M | Buy |
+1,839,200
| New | +$30.5M | 0.1% | 257 |
|
Other funds holding TECH
VCM
VPM
MC
Royce & Associates's TECH Position: Q1 2026 in Review
Royce & Associates increased its Bio-Techne (TECH) stake by 12% in Q1 2026, buying an estimated $4.87M and bringing the position to 759,712 shares worth $39.7M. The position accounts for 0.39% of the portfolio, ranked #59.
Royce & Associates first reported a position in TECH in Q2 2013 and has held it in 52 quarters since. The position peaked at $86.4M in Q2 2016. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.
- Royce & Associates held 759,712 shares of Bio-Techne worth $39.7M as of Q1 2026.
- Royce & Associates bought 81,210 Bio-Techne shares in Q1 2026, an estimated $4.87M.
- Bio-Techne made up 0.39% of Royce & Associates's portfolio in Q1 2026, its #59 holding.
- Royce & Associates first reported a position in Bio-Techne in Q2 2013 and has held it in 52 quarters since.
- Royce & Associates's Bio-Techne position peaked at $86.4M in Q2 2016.
- 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.
Based on Royce & Associates's 13F filing for Q1 2026, filed 12 May 2026.